Rising Star Awards

Prostate Cancer Canada (PCC) is proud to debut the Rising Star in Prostate Cancer Research program, which provide salary and research support for outstanding research scientists initiating careers as independent investigators in prostate cancer research.

These awards provide the opportunity for research scientists within the first 5 years of their first academic or research appointment to develop and demonstrate independence in initiating and conducting prostate cancer research.

The proposed research project must be in the area of prostate cancer and may address any of the broad areas of prostate cancer research, including but not limited to:
  • prostate cancer biology
  • treatment
  • diagnosis
  • survivorship
  • prevention
The amount available for this program is subject to funds raised. The number of awards to be distributed is contingent upon availability of resources and the quality of applications received. The current plan is to distribute four awards with a maximum amount per award of $150,000 per year ($75,000 for salary support and $75,000 for research expenses) for up to 3 years.

For more details on this award, please click here.


2012 Rising Star in Prostate Cancer Research
Review Panel

If you are seeking clarifications, please refer to the FAQs prior to contacting PCC. The FAQs document will continue to be updated as questions are put forward.
Kim Chi, Co-chair
 

Anne-Marie Mes-Masson, Co-chair


Glenn Baumann


Inka Brockhausen


Ralph Buttyan


Gerardo Ferbeyre


Jacques Lapointe


Winston Isaac
Vancouver Prostate Centre
Vancouver, BC

Centre de recherché du Centre Hospitalier de l'Université de Montréal
Montreal, QC

University of Western Ontario
London, ON

Queen’s University
Kingston, ON

Vancouver Prostate Centre
Vancouver, BC

University of Montreal
Montreal, QC

McGill University Health Centre Research Institute
Montreal, QC

Lay member   
Brampton, ON

 

 



Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
New test developed to detect men at high risk of prostate cancer recurrence

Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). More

CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be

Toronto, ON – March 10, 2014 – There is no disputing a cancer diagnosis is among the worst news a person or their family could receive. More

$1.8 Million awarded to Movember Rising Stars Supporting Innovators in Prostate Cancer Research

Toronto, ON – February 12, 2014 – Prostate Cancer Canada (PCC) is proud to announce the recipients of its 2014 Movember Rising Star awards in prostate cancer research. More

Support for Those Affected by Prostate Cancer

Toronto, ON - January 28, 2014 – We are pleased to announce a partnership between Prostate Cancer Canada and the Canadian Cancer Society in launching the Prostate Cancer Information Service (PCIS), which provides support to anyone affected by prostate cancer. More


Click here for news archive